Telix Pharmaceuticals Limited

TLX | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.31

-$1.28 (-10.17%)

At close: Sep 21, 2026, 4:00 PM ET

$11.98

+$0.67 (+5.92%)

Pre-market: Sep 22, 2026, 9:07 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q4 2025 Dec 30, 2025	Q2 2025 Jun 29, 2025	Q4 2024 Dec 30, 2024	Q2 2024 Jun 29, 2024	Q4 2023 Dec 30, 2023	Q2 2023 Jun 29, 2023	Q4 2022 Dec 30, 2022	Q2 2022 Jun 29, 2022	Q4 2021 Dec 30, 2021	Q2 2021 Jun 29, 2021
Cash & Equivalents	363.63M	212.53M	317.84M	710.35M	118.84M	123.24M	131.73M	116.33M	122.61M	22.04M	49.62M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	58.33M	55.57M	6.22M	6.09M	10.46M	12.26M	-5.55M	-5.52M	n/a	n/a	183K
Other Long-Term Assets	48.91M	43.18M	82.48M	74.58M	287.54M	586K	450K	327K	-3.81M	-3.89M	-58.36M
Receivables	245.96M	207.29M	198.73M	158.99M	97.27M	64.78M	64.53M	39.35M	16.91M	19.42M	365K
Inventory	56.34M	55.55M	54.05M	38.14M	30.8M	17.31M	12.6M	8.48M	6.53M	3.45M	889K
Other Current Assets	38.53M	n/a	40.05M	n/a	8.35M	7.1M	10.43M	6.57M	3.44M	1.43M	19.44M
Total Current Assets	704.46M	494.79M	610.67M	918.56M	255.26M	224.85M	219.29M	173.23M	149.5M	47.54M	70.31M
Property-Plant & Equipment	187.12M	173.2M	113.81M	54.32M	38.26M	30.49M	23.09M	18.84M	8.49M	6.33M	4.58M
Goodwill & Intangibles	843.88M	888.11M	896.29M	416.13M	117.75M	109.66M	64.38M	64.5M	61.77M	59.83M	57.94M
Total Long-Term Assets	1.26B	1.28B	1.22B	597.87M	490.7M	173.45M	91.04M	87.36M	66.45M	62.27M	58.54M
Total Assets	1.97B	1.77B	1.83B	1.52B	745.96M	398.3M	310.34M	255.35M	215.94M	109.81M	128.84M
Account Payables	243.91M	107.36M	79.3M	68.7M	22.31M	32.84M	58.69M	16.81M	20.16M	11.88M	11.14M
Deferred Revenue	562.97K	17.18M	6.75M	11.25M	12.38M	11M	8.36M	3.35M	10.24M	6.14M	3.04M
Short-Term Debt	22.26M	19.64M	19.48M	18.99M	1.9M	964K	851K	636.24K	555K	19K	552K
Other Current Liabilities	4.94M	99.6M	134.73M	109.67M	150.02M	44.47M	44.57M	23.04M	19.01M	7.66M	6.17M
Total Current Liabilities	349.82M	347M	458.11M	330.91M	258.37M	157.41M	142.63M	85.56M	46.55M	37.98M	22.29M
Long-Term Debt	728.79M	587.13M	569.95M	551.82M	9.95M	8.21M	5.57M	3.31M	2.01M	n/a	1.14M
Other Long-Term Liabilities	34.78M	35.7M	49.15M	44.68M	65.27M	60.02M	79.4M	79.99M	61.98M	67.77M	27.99M
Total Long-Term Liabilities	912.05M	801.64M	720.24M	617.31M	83.61M	91.98M	91.65M	92.88M	63.99M	68.19M	57.57M
Total Liabilities	1.26B	1.15B	1.18B	948.22M	341.98M	249.39M	234.28M	175.35M	110.53M	107.66M	80.91M
Total Debt	837.03M	699.77M	641.72M	581.45M	22.14M	17.45M	13.1M	10.45M	2.57M	2.54M	1.7M
Book Value	703.96M	622.27M	647.38M	568.21M	403.97M	148.91M	76.06M	80.01M	105.41M	2.16M	47.93M
Book Value Per Share	1.97	1.84	1.92	1.65	1.15	0.46	0.24	0.25	0.34	0.01	0.17
Common Stock	708.64M	719.03M	473.11M	596.78M	587.41M	446.27M	391.9M	370.97M	344.11M	170.84M	167.91M
Retained Earnings	-160.08M	-231.51M	-231.65M	-212.96M	-233.5M	-263.67M	-285.22M	-272.82M	-244.36M	-173.47M	-125.48M
Comprehensive Income	155.39M	134.76M	153.14M	184.4M	50.07M	-33.69M	-30.62M	-18.15M	5.66M	4.79M	5.5M
Shareholders Equity	703.96M	622.27M	647.38M	568.21M	403.97M	148.91M	76.06M	80.01M	105.41M	2.16M	47.93M
Total Investments	58.33M	55.57M	6.22M	6.09M	10.46M	12.26M	-5.55M	-5.52M	n/a	n/a	183K